Stocks Climb on Factory Data as Dollar Rises and Metals Drop | The Close 2/2/2026

Watch on YouTube ↗  |  February 03, 2026 at 00:20  |  1:34:59  |  Bloomberg Markets
Speakers
Mitchell Krebs — Chairman and CEO, Coeur Mining
David Joyce — Head of Digital Assets, Citi
Sherry Paul — Managing Director, Morgan Stanley Private Wealth Management
Brent Thill — Analyst, Jefferies
Asadd Haider — Head of Health Care Business Unit, Goldman Sachs Research
Rashaun Williams — Founder, Harbinger Sports Partners
Raghuram Rajan — Former Governor of the Reserve Bank of India / Professor of Finance
Atsi Sheth — Chief Credit Officer, Moody's Ratings
Norah Mulinda — Market Reporter, Bloomberg
Tim Stenovec — Anchor/Co-Host, Bloomberg TV & Radio
Carol Massar — Anchor, Bloomberg
Ed Ludlow — Co-Host, Bloomberg Technology
Gary Vaynerchuk — Chairman of VaynerX and CEO and Creator of VeeFriends
Eddie Hearn — Boxing Promoter, Matchroom Sport Group
Romaine Bostick — Anchor, Bloomberg

Summary

Stocks rose as stronger U.S. manufacturing data pushed the S&P 500 near a record and lifted Treasury yields and the dollar, while gold and silver sold off. Guests debated Fed leadership under Kevin Warsh, AI-related debt and credit risk, and stretched valuations in AI names such as Oracle and Palantir. Coeur Mining's CEO remained structurally bullish on gold and silver, while analysts discussed Disney earnings, upcoming pharma catalysts, and sports-business investment trends.

  • U.S. manufacturing rebounded in January, lifting equities, yields, and the dollar while pressuring metals.
  • Former RBI Governor Raghuram Rajan discussed how Kevin Warsh may run the Fed and communicate policy.
  • Moody's Atsi Sheth flagged AI capex and data-center debt as a risk if productivity returns disappoint.
  • Oracle's $25 billion bond sale for AI funding renewed investor concern about leverage and returns.
  • Palantir beat estimates, but Jefferies' Brent Thill preferred Meta over Palantir on valuation.
  • Coeur Mining's CEO said gold and silver have durable macro and industrial demand tailwinds.
  • Health-care analysts previewed Pfizer and Bristol-Myers pipeline and patent-headwind stories.
  • Sports and advertising segments covered the Seahawks sale, sports-team economics, Super Bowl ads, and boxing/UFC competition.
Ideas
David Joyce Head of Digital Assets, Citi 20:27
Disney offers long-term diversified brand value
Joyce says Disney's quarter was broadly as expected with better parks margins and direct-to-consumer performance. Near-term marketing and sports costs are pressures, but the back half should benefit from advertising, cruise ship revenue, and franchise monetization, leaving a diversified long-term brand portfolio comfortable despite a tepid near-term outlook.
Mitchell Krebs Chairman and CEO, Coeur Mining 24:20
Gold has structural central-bank demand tailwind
Krebs says gold is supported by the dollar debasement trade, central banks diversifying away from US Treasuries, expected lower rates, debt and deficits, and geopolitical instability. He sees the critical-metals recognition as a structural shift and does not expect these trends to reverse soon.
Mitchell Krebs Chairman and CEO, Coeur Mining 24:45
Silver gains on macro and industrial demand
Silver has the same macro tailwinds as gold plus hefty industrial demand from electrification, solar panels, distribution, semiconductors, robotic vehicles, data centers, and AI. Because the silver market is smaller, speculation can amplify moves, and Krebs sees the critical-metals demand shift as durable.
Mitchell Krebs Chairman and CEO, Coeur Mining 29:00
Coeur builds North American mining powerhouse
Coeur is creating a North American mining powerhouse through the Silvercrest and New Gold acquisitions, with top-five scale and a Canada/US/Mexico footprint that offers lower-jurisdiction-risk exposure. Krebs says metals equities have not yet reflected higher gold and silver prices, and upcoming earnings should begin showing large cash-flow quarters.
Sherry Paul Managing Director, Morgan Stanley Private Wealth Management 38:20
Large caps can fund AI adaptation
Paul is centering portfolios on large caps with big balance sheets that can pay for and absorb the rapid pace of technological change. She expects big companies to keep getting bigger because every company is becoming a tech company, while laggards face extinction-level risk.
Sherry Paul Managing Director, Morgan Stanley Private Wealth Management 38:32
AI installation trade spans sectors
Paul sees the AI buildout broadening into an installation and productivity trade across healthcare, financials, and manufacturing. She urges investing in the multiyear trend rather than a short-term trade, as AI adoption creates survival risk for laggards and productivity gains for adopters.
Sherry Paul Managing Director, Morgan Stanley Private Wealth Management 42:42
Software is losing capital flow
Paul says she has rotated out of software recently because capital flows are moving toward AI infrastructure and the AI arms race. She prefers durable multiyear themes over owning software as a trade.
Brent Thill Analyst, Jefferies 65:42
Prefer Meta over expensive Palantir valuation
Thill says Palantir's fundamentals are excellent, especially commercial growth above 115%, but the stock is one of the most expensive at about 45 times revenue and more than 200 times earnings. He prefers Meta at mid-20s earnings and argues valuation matters, so Palantir's multiple can keep compressing.
Brent Thill Analyst, Jefferies 65:42
Prefer Meta over expensive Palantir valuation
Thill says Palantir's fundamentals are excellent, especially commercial growth above 115%, but the stock is one of the most expensive at about 45 times revenue and more than 200 times earnings. He prefers Meta at mid-20s earnings and argues valuation matters, so Palantir's multiple can keep compressing.
Asadd Haider Head of Health Care Business Unit, Goldman Sachs Research 67:52
Pfizer needs obesity pipeline wins
Haider says Pfizer enters the first of three consecutive years of compounding patent headwinds, so near-term numbers matter less than the narrative. The story depends on acquisitions and obesity/oncology pipeline wins, especially the monthly obesity drug readout, to offset those headwinds.
Asadd Haider Head of Health Care Business Unit, Goldman Sachs Research 71:59
Bristol-Myers needs pipeline wins to re-rate
Haider says Bristol-Myers has no obvious net growth story and trades at a huge discount of under 9 times earnings versus 14-15 times peers. The 2026 story depends on pipeline wins after 2025 setbacks, and some high-risk fourth-quarter readouts make the setup challenging.
Rashaun Williams Founder, Harbinger Sports Partners 77:38
Braves grow revenue via real estate
Williams cites Atlanta Braves as a publicly traded sports team that grew revenue from $250 million to $650 million by diversifying from league and sponsorship revenue into stadium, parking, commercial, and residential real estate. He argues sports teams are becoming holding/media/live-event/real-estate companies with multiple ways to monetize IP year-round.
Up Next

This Bloomberg Markets video, published February 03, 2026, features David Joyce, Mitchell Krebs, Sherry Paul, Brent Thill, Asadd Haider, Rashaun Williams discussing DIS, GLD, SILVER, CDE, Large-cap Equities, XLV, XLF, Manufacturing, IGV, PLTR, META, PFE, BMY, BATRA. 12 trade ideas extracted by AI with direction and confidence scoring.

Speakers: David Joyce, Mitchell Krebs, Sherry Paul, Brent Thill, Asadd Haider, Rashaun Williams  · Tickers: DIS, GLD, SILVER, CDE, Large-cap Equities, XLV, XLF, Manufacturing, IGV, PLTR, META, PFE, BMY, BATRA